Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

2019

Slider News

2019

  • 2019 - 01 - 28

    Press Release

  • 2019 - 02 - 05

    Press Release

  • 2019 - 02 - 20

    Press Release

  • 2019 - 02 - 23

    Press Release

  • 2019 - 03 - 01

    Press Release

  • 2019 - 03 - 12

    Press Release

  • 2019 - 03 - 12

    Press Release

  • 2019 - 03 - 25

    Menarini at Bio Pharma Day in Milan

  • 2019 - 03 - 29

    Press Release

  • FdB_presentazione visual_2019_DEFINITIVO

    2019 - 04 - 02

    Children's Florence: 12nd - 14th April 2019

  • 2019 - 04 - 09

    LimitLess - Press Release

  • 2019 - 04 - 19

    Press Release

  • 2019 - 05 - 10

    Press Release

  • 2019 - 05 - 22

    Press Release

  • 2019 - 05 - 23

    Menarini Ricerche at the ASCO Annual Meeting 2019 with three different projects in oncology

  • 2019 - 05 - 29

    The Fondazione Internazionale Menarini receives an award from the Ministry of Health of the Republic of Singapore

  • 2019 - 06 - 10

    Menarini Ricerche at the 24th EHA congress presenting the First In Human clinical study of SEL24/MEN1703

  • 2019 - 06 - 17

    Programme and winners of the 23rd fair play-menarini international awards revealed at the coni hall of honour

  • 2019 - 06 - 28

    Menarini Ricerche announces publication of pre-clinical data of the first-in-class antibody-drug conjugate MEN1309/OBT076,

  • 2019 - 07 - 03

    Menarini’s evening with the stars of Fair Play

  • 2019 - 09 - 23

    ESMO Annual Meeting 2019: Menarini Ricerche presents the preclinical characterization of MEN1611, a novel PI3K inhibitor in development for the treatm

  • 2019 - 09 - 23

    The delicate artistry of Fra Angelico is now a part of the Menarini Art Series

  • 2019 - 12 - 09

    61st ASH Congress 2019: Menarini Ricerche presents the latest updates about the First In Human clinical trial of SEL24/MEN1703

  • 2019 - 12 - 20

    Menarini’s Sustenium product line launched on Tmall